SCHEMBL4351077

SCHEMBL4351077

O=[N+]([O-])c1cc(F)c(O)c(NCc2ccccc2Sc2ccccc2Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.47
MAPT P10636 9/20 0.46
KMT2A Q03164 6/20 0.46
MEN1 O00255 5/20 0.46
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
GAA P10253 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 4/20 0.43
ALDH1A1 P00352 2/20 0.41
PDE7A Q13946 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345417 0.89 SLC6A4 (0.42) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4345686 0.89 SLC6A4 (0.41) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4350287 0.88 MAPT (0.41) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4345853 0.87 MAPT (0.41) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4349817 0.87 SLC6A4 (0.45) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4342384 0.84 MAPT (0.41) SLC6A4MAPTKMT2AMEN1GAA
SCHEMBL4358425 0.82 MEN1 (0.49) MAPTKMT2AMEN1GAAPKM
SCHEMBL4354729 0.81 PRMT3 (0.40) SLC6A4MAPTKMT2AMEN1PLA2G1B
SCHEMBL4346171 0.81 ALDH1A1 (0.51) SLC6A4MAPTKMT2AMEN1GAA
SCHEMBL4345875 0.81 MAPT (0.42) MAPTKMT2AMEN1GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 SLC6A4 1100/4885MAPT 4439/4885KMT2A 2096/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 SLC6A4 1325/4885MAPT 4184/4885KMT2A 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.